608 related articles for article (PubMed ID: 31155146)
1. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
3. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Khunti K; Godec TR; Medina J; Garcia-Alvarez L; Hiller J; Gomes MB; Cid-Ruzafa J; Charbonnel B; Fenici P; Hammar N; Hashigami K; Kosiborod M; Nicolucci A; Shestakova MV; Ji L; Pocock S
Diabetes Obes Metab; 2018 Feb; 20(2):389-399. PubMed ID: 28817227
[TBL] [Abstract][Full Text] [Related]
4. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
[TBL] [Abstract][Full Text] [Related]
5. Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study.
Mahmoud F; Mueller T; Mullen A; Sainsbury C; Rushworth GF; Kurdi A
Diabetes Obes Metab; 2024 Jul; 26(7):2684-2694. PubMed ID: 38558305
[TBL] [Abstract][Full Text] [Related]
6. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
Burgmann K; Fatio S; Jordi B; Rutishauser J
Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
[TBL] [Abstract][Full Text] [Related]
7. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
[TBL] [Abstract][Full Text] [Related]
8. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM
Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Effect of Early Versus Delayed Metformin Treatment on Glycaemic Parameters Among Australian Adults With Incident Diabetes: Evidence Using a National General Practice Database.
Zheng M; Begum M; Bernardo CO; Stocks N; Gonzalez-Chica D
Clin Ther; 2024 May; 46(5):396-403. PubMed ID: 38565499
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.
Overbeek JA; Heintjes EM; Prieto-Alhambra D; Blin P; Lassalle R; Hall GC; Lapi F; Bianchini E; Hammar N; Bezemer ID; Herings RMC
Clin Ther; 2017 Apr; 39(4):759-770. PubMed ID: 28342563
[TBL] [Abstract][Full Text] [Related]
14. Prescription Patterns and Disease Control in Type 2 Diabetes Mellitus Patients in Nursing Home and Home Care Settings: A Retrospective Analysis in Germany.
Kostev K; Rockel T; Jacob L
J Diabetes Sci Technol; 2018 Jan; 12(1):136-139. PubMed ID: 28539088
[TBL] [Abstract][Full Text] [Related]
15. Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017.
Wilkinson S; Douglas I; Stirnadel-Farrant H; Fogarty D; Pokrajac A; Smeeth L; Tomlinson L
BMJ Open; 2018 Jul; 8(7):e022768. PubMed ID: 30056393
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
Heintjes EM; Overbeek JA; Hall GC; Prieto-Alhambra D; Lapi F; Hammar N; Bezemer ID
Clin Ther; 2017 Nov; 39(11):2296-2310.e14. PubMed ID: 29108837
[TBL] [Abstract][Full Text] [Related]
17. Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.
Wilding J; Godec T; Khunti K; Pocock S; Fox R; Smeeth L; Clauson P; Fenici P; Hammar N; Medina J
BMC Med; 2018 Jul; 16(1):116. PubMed ID: 30008267
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis.
Wu D; Li L; Liu C
Diabetes Obes Metab; 2014 Jan; 16(1):30-7. PubMed ID: 23803146
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Nicolucci A; Charbonnel B; Gomes MB; Khunti K; Kosiborod M; Shestakova MV; Shimomura I; Watada H; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Pocock S
Diabetes Obes Metab; 2019 Nov; 21(11):2474-2485. PubMed ID: 31297947
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis.
Nishimura R; Takeshima T; Iwasaki K; Aoi S
BMJ Open; 2022 Mar; 12(3):e045966. PubMed ID: 35277396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
